Facente Consulting served as the lead evaluator for a local LGBTQ+ mental health-focused impact evaluation that involved evaluation design, managing IRB approvals, overseeing data collection, and quantitative analysis.
Project Descriptions
Impact Evaluation of a Social Connection Intervention to Improve LGBTQ+ Mental Health
Needs Assessment of Hepatitis C Testing and Treatment in the Jail System
End Hep C SF
Facente Consulting was selected by End Hep C SF to design and lead a mixed-methods needs assessment to identify gaps in hepatitis C (HCV) testing and treatment in San Francisco jails, identify best practices for treatment and linkage, and develop a HCV care cascade for people currently or recently incarcerated.
National HIV Behavioral Surveillance (NHBS) Data Analysis
CDPH Office of AIDS
Collective Impact Backbone Support and Data Analysis to Eliminate Hepatitis C
End Hep C SF
Project Coordination and Analytic Support to Improve Global HIV Incidence Estimation
The Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
Evaluation for CDC-Funded Syringe Service Program Vaccine Scale-Up
NASTAD
Evaluation for CDC-Funded Workforce Development for San Francisco Department of Public Health
SFDPH Center for Learning and Innovation
Assistance to Develop a System of Panel Management within a Jail Medical System
SFDPH Jail Health Services
Statistical Analysis to Support Evaluation of a LGBTQ+ Mental Health Intervention
LGBTQ Connection
Evaluating Naloxone Boxes to Prevent Overdoses in Michigan
Harm Reduction Michigan
Tobacco Free Project Quantitative Data Analysis
San Francisco Tobacco-Free Project
Research Coordination and Data Analysis for an NIH R21 Study on Hepatitis C Epidemiology
University of California, San Francisco (UCSF) - CFAR/Gladstone Institute
Formal Assessment of the Landscape of Medication-Assisted Treatment Programs in California
The Center at Sierra Health Foundation
Development and Implementation of Organizational Impact Evaluation
San Francisco AIDS Foundation
Test and Be Treated (TBT) Study Data Analysis
University of California, San Francisco (UCSF)
Statistical Support for an Advanced HIV Prevention Clinical Trial Design
Gilead Sciences
Facente Consulting supported Gilead Sciences with statistical analysis relating to HIV incidence rates, assisting with the study design, analysis plan, and interpretation of study data for the PURPOSE trials–ultimately leading to the groundbreaking FDA approval of the twice-yearly PrEP medication Lenacapavir.